Transthyretin (ATTR) amyloidosis nephropathy: lessons from a TTR stabilizer molecule

Amyloid. 2017 Mar;24(sup1):81-82. doi: 10.1080/13506129.2016.1277697.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Adult
  • Amyloid / antagonists & inhibitors*
  • Amyloid / genetics
  • Amyloid / metabolism
  • Amyloid Neuropathies, Familial / drug therapy*
  • Amyloid Neuropathies, Familial / genetics
  • Amyloid Neuropathies, Familial / pathology
  • Benzoxazoles / therapeutic use*
  • Biomarkers / urine
  • Creatinine / urine
  • Cystatin C / urine
  • Drug Administration Schedule
  • Female
  • Gene Expression
  • Glomerular Filtration Rate
  • Humans
  • Kidney / drug effects
  • Kidney / pathology
  • Male
  • Middle Aged
  • Mutation
  • Nephritis / drug therapy*
  • Nephritis / genetics
  • Nephritis / pathology
  • Prealbumin / antagonists & inhibitors*
  • Prealbumin / genetics
  • Prealbumin / metabolism
  • Prospective Studies
  • Proteinuria / drug therapy*
  • Proteinuria / genetics
  • Proteinuria / pathology

Substances

  • Amyloid
  • Benzoxazoles
  • Biomarkers
  • Cystatin C
  • Prealbumin
  • tafamidis
  • Creatinine

Supplementary concepts

  • Amyloidosis, Hereditary, Transthyretin-Related